Pettyjohn Wood & White’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12M Buy
47,788
+169
+0.4% +$36.4K 1.75% 16
2026
Q1
$10.4M Buy
47,619
+328
+0.7% +$72.8K 1.65% 16
2025
Q4
$10.8M Sell
47,291
-144
-0.3% -$32.8K 1.69% 17
2025
Q3
$11M Buy
47,435
+72
+0.2% +$14.7K 1.81% 14
2025
Q2
$8.79M Buy
47,363
+698
+1% +$130K 1.57% 17
2025
Q1
$9.78M Sell
46,665
-2,908
-6% -$565K 1.87% 13
2024
Q4
$8.81M Buy
49,573
+598
+1% +$110K 1.61% 17
2024
Q3
$9.67M Sell
48,975
-519
-1% -$96.9K 1.78% 15
2024
Q2
$8.49M Sell
49,494
-270
-0.5% -$44.7K 1.65% 17
2024
Q1
$9.06M Sell
49,764
-258
-0.5% -$44.5K 1.8% 15
2023
Q4
$7.75M Sell
50,022
-118
-0.2% -$17.2K 1.68% 17
2023
Q3
$7.47M Hold
50,140
1.76% 15
2023
Q2
$6.76M Buy
50,140
+85
+0.2% +$12.5K 1.55% 19
2023
Q1
$7.98M Buy
50,055
+750
+2% +$115K 1.95% 14
2022
Q4
$7.97M Sell
49,305
-200
-0.4% -$30.7K 1.99% 14
2022
Q3
$6.64M Sell
49,505
-429
-0.9% -$61.6K 1.77% 17
2022
Q2
$7.65M Buy
49,934
+2,092
+4% +$320K 1.81% 17
2022
Q1
$7.76M Sell
47,842
-985
-2% -$143K 1.66% 20
2021
Q4
$6.61M Buy
48,827
+461
+1% +$54.5K 1.36% 27
2021
Q3
$5.22M Buy
48,366
+6,239
+15% +$713K 1.16% 33
2021
Q2
$4.75M Buy
42,127
+2,602
+7% +$293K 1.06% 36
2021
Q1
$4.28M Buy
39,525
+1,989
+5% +$213K 1.01% 37
2020
Q4
$4.02M Buy
37,536
+966
+3% +$92.8K 1.03% 35
2020
Q3
$3.2M Buy
36,570
+2,855
+8% +$269K 0.94% 38
2020
Q2
$3.31M Buy
33,715
+1,218
+4% +$107K 1.06% 32
2020
Q1
$2.48M Buy
32,497
+2,632
+9% +$224K 0.92% 40
2019
Q4
$2.64M Buy
29,865
+601
+2% +$49.9K 0.76% 43
2019
Q3
$2.22M Buy
29,264
+5,545
+23% +$380K 0.67% 45
2019
Q2
$1.73M Buy
23,719
+1,969
+9% +$155K 0.53% 54
2019
Q1
$1.75M Buy
21,750
+6,395
+42% +$523K 0.57% 50
2018
Q4
$1.42M Sell
15,355
-50
-0.3% -$4.4K 0.52% 52
2018
Q3
$1.46M Sell
15,405
-50
-0.3% -$4.74K 0.47% 59
2018
Q2
$1.43M Buy
15,455
+117
+0.8% +$11.4K 0.5% 61
2018
Q1
$1.45M Sell
15,338
-565
-4% -$62.1K 0.53% 59
2017
Q4
$1.54M Sell
15,903
-1,245
-7% -$117K 0.55% 56
2017
Q3
$1.52M Sell
17,148
-1,042
-6% -$79.3K 0.57% 57
2017
Q2
$1.32M Sell
18,190
-31,969
-64% -$2.15M 0.49% 61
2017
Q1
$3.27M Buy
50,159
+255
+0.5% +$16K 1.21% 32
2016
Q4
$3.13M Sell
49,904
-8,010
-14% -$489K 1.21% 30
2016
Q3
$3.65M Buy
57,914
+275
+0.5% +$17.8K 1.74% 16
2016
Q2
$3.57M Buy
57,639
+945
+2% +$57.6K 1.41% 25
2016
Q1
$3.24M Buy
56,694
+1,418
+3% +$79K 1.32% 26
2015
Q4
$3.27M Buy
55,276
+900
+2% +$51.8K 1.39% 24
2015
Q3
$2.96M Sell
54,376
-650
-1% -$42.3K 1.36% 27
2015
Q2
$3.7M Buy
55,026
+25
+0% +$1.63K 1.56% 20
2015
Q1
$3.22M Buy
55,001
+8,050
+17% +$486K 1.33% 25
2014
Q4
$3.07M Sell
46,951
-100
-0.2% -$6.3K 1.27% 28
2014
Q3
$2.72M Hold
47,051
1.17% 29
2014
Q2
$2.66M Buy
47,051
+100
+0.2% +$5.25K 1.16% 29
2014
Q1
$2.41M Buy
46,951
+2,500
+6% +$126K 1.1% 31
2013
Q4
$2.35M Sell
44,451
-750
-2% -$36.9K 1.37% 26
2013
Q3
$2.02M Buy
45,201
+267
+0.6% +$11.8K 1.25% 29
2013
Q2
$1.86M Buy
+44,934
New +$1.97M 1.17% 31

Other funds holding ABBV

Pettyjohn Wood & White's ABBV Position: Q2 2026 in Review

Pettyjohn Wood & White increased its AbbVie (ABBV) stake by 0.35% in Q2 2026, buying an estimated $36.4K and bringing the position to 47,788 shares worth $12M. The position accounts for 1.75% of the portfolio, ranked #16.

Pettyjohn Wood & White first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Pettyjohn Wood & White held 47,788 shares of AbbVie worth $12M as of Q2 2026.
  • Pettyjohn Wood & White bought 169 AbbVie shares in Q2 2026, an estimated $36.4K.
  • AbbVie made up 1.75% of Pettyjohn Wood & White's portfolio in Q2 2026, its #16 holding.
  • Pettyjohn Wood & White first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Pettyjohn Wood & White's 13F filing for Q2 2026, filed 12 Aug 2026.